top of page

Opinion: Medicare’s drug price ‘negotiations’ are anything but

President Joe Biden’s Inflation Reduction Act gave the government sweeping new power to set the price Medicare will pay for an annually expanding list of medications. This August, the Centers for Medicare & Medicaid Services announced the first 10 drugs subject to what Health and Human Services Secretary Xavier Becerra insists on calling voluntary negotiations.


We Work For Health brings together national and local business leaders, labor, biopharma, patient advocacy, and other healthcare-related stakeholders to support policies and initiatives that foster innovation and facilitate the delivery of lifesaving and life-enhancing medicines. 

We Work For Health. © 2023 All Rights Reserved.

bottom of page